Adiponectin acts by interacting with AdipoR1 and AdipoR2, and the discovery of adiponectin and its receptors over the past two decades has led to a better understanding of metabolic disorders development (Kadowaki and Yamauchi 2005; Li et al. 2017a, b; Sun et al. 2019). This evidence concerns the gene ADIPOQ and metabolic disease.